George Church (Mary Altaffer/AP Images)

ARCH-backed George Church spin­out shuts down af­ter gene ther­a­py tech strug­gles in an­i­mal mod­els

Har­vard bio­engi­neer George Church likes stu­dents with big ideas and he likes to help them make those ideas a re­al­i­ty, serv­ing as a co-founder or ad­vi­sor on dozens of the zany and am­bi­tious star­tups to spin out of his lab.

But not all ideas are quite ready to change med­i­cine.

Al­ly Ther­a­peu­tics, a gene ther­a­py biotech that launched out of Church’s lab in 2018 and lat­er raised seed cash from ARCH and oth­er blue-chip VCs, shut down ear­li­er this year, board mem­ber Bob More con­firmed in an email.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.